StockData

China SXT Pharmaceuticals, Inc. (SXTC) stock

SXTCNasdaqPharmaceutical PreparationsFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 1, 2026Score 4/30
$2.83−0.03 (-1.05%)

Close on Nov 18, 2026Market cap $2.71MP/E –Yield –

China SXT Pharmaceuticals shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

For fiscal 2026 it was 1M, up 7062.5% from the year before. The highest annual figure on record is 6M in fiscal 2020.

Annual shares outstanding

PeriodPeriod endValueChange
FY2026Mar 31, 20261M+7062.5%
FY2025Mar 31, 20250M+1212.4%
FY2024Mar 31, 20240M-97.8%
FY2023Mar 31, 20230M-19.8%
FY2022Mar 31, 20220M-94.2%
FY2021Mar 31, 20211M-88.4%
FY2020Mar 31, 20206M+20.2%
FY2019Mar 31, 20195M+2.8%
FY2018Mar 31, 20185M0.0%
FY2017Mar 31, 20175M–

More China SXT Pharmaceuticals figures

See a number that looks wrong?